MedTrace Logo

Factors Predicting The Success of Ejaculation Sparing Transurethral Resection of Prostate in Benign Prostatic Hyperplasia Patients

NCT07513896 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2026-04-07

No results posted yet for this study

Summary

evaluate the factors predicting the success of ejaculation-sparing TURP in patients with BPH after surgery, in terms of voiding improvement and preserved ejaculation post-operatively.

Conditions

  • Benign Prostatic Hyperplasia
  • Ejaculation

Interventions

PROCEDURE

ejaculatory preserving TURP

In our study, we performed an EP-TURP technique, which is adopted in our institute and involves the preservation of 1 cm of urethral mucosa all around the verumontanum, including the prostatic apical urethral mucosa, with adequate resection of the prostatic adenoma, including the apical prostatic tissue, which was resected lateral to the spared urethral mucosa to ensure adequate management of the outflow obstruction. (8). Bi-polar TURP was performed using a 26 Fr. Resectoscope (Karl Storz, Tuttlingen, Germany) and Karl Storz- AUTOCON® IV. Intraoperative cystoscopic evaluation and documentation of the prostatic anatomy were done. SML was measured cystoscopically using a 22 Fr sheath with centimeter markings. Operative time, perioperative complications, catheterization duration, and hospital stay were recorded. Urethral catheter removal was planned after 24-48 hours unless prolonged catheterization was clinically indicated.

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-12
Primary Completion
2025-12-12
Completion
2026-01-25

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07513896 on ClinicalTrials.gov